Menelik MH Lee, MBBS, MRCOG, FHKCOG, FHKAM; Charles J Carter, MBChB, FRCS(urol); Tyrone T Carpenter, MBBS, BSc, MRCOG, MD, 20140601000000
Laparoscopic partial cystectomy is established as the optimal treatment of full thickness bladder endometriosis. Complete excision of the lesion is essential however over excision risks unnecessary reduction in bladder volume and may risk ureteric obstruction. The following case demonstrates a new technique of cystoscopic mapping and laparoscopic resection of bladder endometriosis, allowing complete removal of the endometriotic nodule while sparing maximum bladder capacity and minimising risk of injury to the ureteric orifices.
Krukenberg tumour is a metastatic signet ring cell adenocarcinoma of the ovary. This tumour is uncommon, accounting for 1–2% of all ovarian tumours. The stomach is the primary site in most Krukenberg tumour cases (70%), and the prognosis is generally poor. We report a case of a pregnant lady who was incidentally found to have a large ovarian mass during caesarean section which was later confirmed to be a Krukenberg tumour.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS JPOG - Malaysia digital copy today!
Group B Streptococcus (GBS) is the commonest cause of severe early-onset neonatal infection, which is associated with a high rate of morbidity and mortality (5–10%).1-3 About half of GBS meningitis will be complicated by neurodevelopment impairment. Because the early-onset disease develops shortly and rapidly after birth, there has been little improvement in the disease treatment, and the focus thus lies in disease prevention.
Dr Tan Toh Lick, Consultant Obstetrician and Gynaecologist at Thomson
Women’s Clinic, and Thomson Wellth Clinic Singapore, shares the complexities
of diagnosing polycystic ovarian syndrome in adolescent girls
Evacuation proctography, magnetic resonance imaging, and transperineal and endovaginal ultrasonography demonstrate similar diagnostic test accuracy for posterior pelvic floor disorders in women with obstructed defecation syndrome, a recent study has shown.
Results of a recent clinical trial showed that treatment with niraparib, a poly ADP ribose polymerase (PARP) inhibitor, improved progression-free survival (PFS) by more than 15 months in patients with recurrent ovarian cancer responding to platinum.